Fingerprint
Dive into the research topics of 'Safety and efficacy of AMG 334 for prevention of episodic migraine: A randomised, double-blind, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and efficacy of AMG 334 for prevention of episodic migraine: A randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun, David W. Dodick, Stephen Silberstein, Peter J. Goadsby, Uwe Reuter, Messoud Ashina, Joel Saper, Roger Cady, Yun Chon, Julie Dietrich, Robert Lenz
Research output: Contribution to journal › Article › peer-review
197
Scopus
citations